• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管炎:疾病模式的决定因素。

Vasculitis: determinants of disease patterns.

机构信息

Department of Rheumatic and Immunologic Diseases, A50, 9500 Euclid Avenue, Lerner College of Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.

出版信息

Nat Rev Rheumatol. 2014 Aug;10(8):454-62. doi: 10.1038/nrrheum.2014.89. Epub 2014 Jun 17.

DOI:10.1038/nrrheum.2014.89
PMID:24934189
Abstract

The vasculitides are a large group of heterogeneous diseases for which it has been assumed that pathogenesis is largely autoimmune. As clinicians, we distinguish one form of vasculitis from another on the basis of observed patterns of organ injury, the size of the vessels affected and histopathological findings. The terms 'small-vessel', 'medium-vessel' and 'large-vessel' vasculitis are useful clinical descriptors, but fail to inform us about why vessels of a certain calibre are favoured by one disease and not another. Classification based on vessel size also fails to consider that vessels of a specific calibre are not equally prone to injury. Distinct vulnerabilities undoubtedly relate to the fact that same-size vessels in different tissues may not be identical conduits. In fact, vessels become specialized, from the earliest stages of embryonic development, to suit the needs of different anatomical locations. Vessels of the same calibre in different locations and organs are as different as the organ parenchymal cells through which they travel. The dialogue between developing vessels and the tissues they perfuse is designed to meet special local needs. Added to the story of vascular diversity and vulnerability are changes that occur during growth, development and ageing. An improved understanding of the unique territorial vulnerabilities of vessels could form the basis of new hypotheses for the aetiopathogenesis of the vasculitides. This Review considers how certain antigens, including infectious agents, might become disease-relevant and how vascular diversity could influence disease phenotypes and the spectrum of vascular inflammatory diseases.

摘要

血管炎是一组异质性很大的疾病,人们普遍认为其发病机制主要是自身免疫性的。作为临床医生,我们根据观察到的器官损伤模式、受影响血管的大小和组织病理学发现来区分一种血管炎与另一种血管炎。“小血管”、“中血管”和“大血管”血管炎是有用的临床描述性术语,但并不能告诉我们为什么某种特定口径的血管会受到一种疾病的影响而不受另一种疾病的影响。基于血管大小的分类也不能说明为什么特定口径的血管不会同等地受到损伤。不同的易损性无疑与这样一个事实有关,即不同组织中相同口径的血管不一定容易受到损伤。实际上,从胚胎发育的早期阶段开始,血管就会变得专业化,以适应不同解剖部位的需要。不同位置和器官的相同口径的血管与它们所流经的器官实质细胞一样不同。发育中的血管与它们所灌注的组织之间的对话旨在满足特殊的局部需求。除了血管多样性和易损性的故事之外,还有在生长、发育和衰老过程中发生的变化。对血管特有的局部易损性的认识的提高,可以为血管炎的发病机制提供新的假说基础。这篇综述探讨了某些抗原,包括感染因子,如何成为与疾病相关的,以及血管多样性如何影响疾病表型和血管炎性疾病的范围。

相似文献

1
Vasculitis: determinants of disease patterns.血管炎:疾病模式的决定因素。
Nat Rev Rheumatol. 2014 Aug;10(8):454-62. doi: 10.1038/nrrheum.2014.89. Epub 2014 Jun 17.
2
Disease patterns in vasculitis-still a mystery.血管炎的疾病模式——仍是一个谜。
Bull NYU Hosp Jt Dis. 2008;66(3):224-7.
3
[Histology of cutaneous vasculitides].[皮肤血管炎的组织学]
Hautarzt. 2008 May;59(5):363-4, 366-70, 372-3. doi: 10.1007/s00105-008-1545-8.
4
An approach to vasculitis and vasculopathy.一种针对血管炎和血管病变的方法。
Cutis. 2012 May;89(5):E1-3.
5
[Cutaneous vasculitis].[皮肤血管炎]
Actas Dermosifiliogr. 2012 Apr;103(3):179-91. doi: 10.1016/j.ad.2011.06.001. Epub 2011 Aug 12.
6
Vasculitides with cutaneous expression in children: clinico-pathological correlations.儿童具有皮肤表现的血管炎:临床病理相关性
G Ital Dermatol Venereol. 2015 Feb;150(1):51-71. Epub 2014 Dec 17.
7
Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis - part I.血管炎最新进展:临床及组织病理学诊断概述与皮肤学线索——第一部分
An Bras Dermatol. 2020 May-Jun;95(3):355-371. doi: 10.1016/j.abd.2020.01.003. Epub 2020 Mar 26.
8
[Cutaneous symptoms of various vasculitides].[各种血管炎的皮肤症状]
Hautarzt. 2015 Aug;66(8):589-98. doi: 10.1007/s00105-015-3661-6.
9
Working classification of vasculitis.
Int Angiol. 1995 Jun;14(2):101-6.
10
Small-vessel vasculitis.小血管炎。
Dermatol Ther. 2012 Mar-Apr;25(2):148-57. doi: 10.1111/j.1529-8019.2012.01535.x.

引用本文的文献

1
Can we cure vasculitis?我们能治愈血管炎吗?
Curr Opin Immunol. 2025 Jul 28;96:102618. doi: 10.1016/j.coi.2025.102618.
2
Public Awareness and Knowledge Gaps in Osteoarthritis Prevention in the UAE: A Cross-Sectional Study on Risk Factors and Lifestyle Influences.阿联酋骨关节炎预防方面的公众认知与知识差距:一项关于风险因素和生活方式影响的横断面研究。
Cureus. 2025 Jan 24;17(1):e77915. doi: 10.7759/cureus.77915. eCollection 2025 Jan.
3
Central and Peripheral Nervous System Complications of Vasculitis Syndromes from Pathology to Bedside: Part 2-Peripheral Nervous System.

本文引用的文献

1
Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus.黏附、侵袭和逃逸:金黄色葡萄球菌表面蛋白的多种功能。
Nat Rev Microbiol. 2014 Jan;12(1):49-62. doi: 10.1038/nrmicro3161.
2
Defensins in innate immunity.防御素在先天免疫中的作用。
Curr Opin Hematol. 2014 Jan;21(1):37-42. doi: 10.1097/MOH.0000000000000005.
3
Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner.活化的巨噬细胞以肿瘤坏死因子依赖的方式促进丙型肝炎病毒进入。
血管炎综合征的中枢和周围神经系统并发症:从病理学到床边:第 2 部分-周围神经系统。
Curr Neurol Neurosci Rep. 2023 Mar;23(3):83-107. doi: 10.1007/s11910-023-01249-3. Epub 2023 Feb 23.
4
The impact of the COVID-19 pandemic on patients with systemic vasculitis: a single-centre retrospective study.COVID-19 大流行对系统性血管炎患者的影响:一项单中心回顾性研究。
Rheumatol Int. 2023 Mar;43(3):459-466. doi: 10.1007/s00296-023-05276-8. Epub 2023 Jan 16.
5
Endothelial Activation and Immune Thrombocytopenia: An Engagement Waiting for Consolidation.内皮细胞活化与免疫性血小板减少症:一种有待巩固的关联。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211054514. doi: 10.1177/10760296211054514.
6
Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype.抗中性粒细胞胞质抗体相关性血管炎的分类:基于抗中性粒细胞胞质抗体特异性和临床病理表型的差异。
Rheumatol Int. 2021 Oct;41(10):1717-1728. doi: 10.1007/s00296-021-04966-5. Epub 2021 Aug 12.
7
Vasculitis and Breast Cancer: Mind the Hint.血管炎与乳腺癌:留意提示。
Case Rep Oncol. 2021 Mar 22;14(1):550-560. doi: 10.1159/000514729. eCollection 2021 Jan-Apr.
8
In Vitro Human Blood-Brain Barrier Model for Drug Permeability Testing.用于药物渗透性测试的体外人血脑屏障模型
Methods Mol Biol. 2021;2367:73-85. doi: 10.1007/7651_2020_344.
9
Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms.外周炎症与血脑屏障破坏:作用与机制。
CNS Neurosci Ther. 2021 Jan;27(1):36-47. doi: 10.1111/cns.13569. Epub 2020 Dec 30.
10
Update on vasculitis: an overview and dermatological clues for clinical and histopathological diagnosis - part I.血管炎最新进展:临床及组织病理学诊断概述与皮肤学线索——第一部分
An Bras Dermatol. 2020 May-Jun;95(3):355-371. doi: 10.1016/j.abd.2020.01.003. Epub 2020 Mar 26.
Hepatology. 2014 Apr;59(4):1320-30. doi: 10.1002/hep.26911. Epub 2014 Feb 25.
4
Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.丙型肝炎病毒相关冷球蛋白血症性血管炎的治疗。
N Engl J Med. 2013 Sep 12;369(11):1035-45. doi: 10.1056/NEJMra1208642.
5
Hepatitis C virus-induced vasculitis: therapeutic options.丙型肝炎病毒相关性血管炎:治疗选择。
Ann Rheum Dis. 2014 Jan;73(1):24-30. doi: 10.1136/annrheumdis-2013-203883. Epub 2013 Aug 6.
6
Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.不同的清除受体 B 型 I 类在丙型肝炎病毒无细胞与细胞间传播中的要求。
J Virol. 2013 Aug;87(15):8282-93. doi: 10.1128/JVI.01102-13. Epub 2013 May 22.
7
Avian host defense peptides.禽类宿主防御肽。
Dev Comp Immunol. 2013 Nov;41(3):352-69. doi: 10.1016/j.dci.2013.04.019. Epub 2013 May 3.
8
Infections in vasculitis.血管炎中的感染。
Best Pract Res Clin Rheumatol. 2013 Feb;27(1):19-31. doi: 10.1016/j.berh.2013.01.004.
9
The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.HLA-DRB1*15:01 限制性 Goodpasture 细胞 T 细胞表位诱导 GN。
J Am Soc Nephrol. 2013 Feb;24(3):419-31. doi: 10.1681/ASN.2012070705. Epub 2013 Feb 14.
10
Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.丙型肝炎病毒感染、混合性冷球蛋白血症和肾脏疾病。
Am J Kidney Dis. 2013 Apr;61(4):623-37. doi: 10.1053/j.ajkd.2012.08.040. Epub 2012 Oct 25.